Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 4, 1995, Pages 1369-1375

  Gibson, J Martin ^a   Westwood, Melissa ^a   Crosby, Steven R ^b   Gordon, Christopher ^c   Holly, Jeffrey M P ^d   Fraser, William ^e   Anderson, Chris ^e   White, Anne ^a   Young, Robert J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; METFORMIN; PROINSULIN; SOMATOMEDIN BINDING PROTEIN; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

CARRIER PROTEINS; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FASTING; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MALE; METFORMIN; MIDDLE AGED; PROINSULIN; REFERENCE VALUES; SOMATOMEDINS; SULFONYLUREA COMPOUNDS;

EID: 0028936969     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.4.7536208     Document Type: Article

References (28)

1. Hall K, Johansson BL, Povoa G, Thalme B. 1989 Serum levels of insulin-like growth factors (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J Intern Med. 225:273-278.
2. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1,-2,-3,-4,-5,-6). Prog Growth Factor Res. 3:243-266.
3. Sara VR, Hall K. 1990 Insulin-like growth factors and their binding proteins. Physiol Rev. 70:591-614.
4. Clemmons DR. 1990 Insulin-like growth factor binding proteins. Trends Endocrinol Metab. 80:412-417.
5. Conover CA. 1992 Potentiation of insulin-like growth factor (IGF) action by IGFBP-3: studies of underlying mechanism. Endocrinology. 130:3191-3199.
6. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. 1991 Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh). 124:74-85.
7. Holly JMP. 1991 The physiological role of IGFBP-1. Acta Endocrinol (Copenh). 124:55-62.
8. Bar RS, Boes M, Clemmons DR, et al. 1990 Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in the rat heart. Endocrinology. 127:497-499.
9. Unterman TG, Oehler DT, Murphy LJ, Lacson RG. 1991 Multi-hormonal regulation of insulin-like growth factor binding protein-1 in rat H4IIE hepatoma cells: the dominant role of insulin. Endocrinology. 128:2693-2701.
10. Suikkari A-M, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989 Dose response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab. 68:135-140.
11. Suikkari A-M, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA. 1989 Prolonged exercise increases serum insulin-like growth factor concentrations. J Clin Endocrinol Metab. 68:141-144.
12. Taylor AM, Dunger DB, Preece MA, et al. 1990 The growth hormone independent insulin-like growth factor-1 binding protein BP-28 is associated with serum insulin-like growth factor-1 inhibitory bioactivity in adolescent insulin dependent diabetics. Clin Endocrinol (Oxf). 32:229-239.
13. Grant M, Russell B, Fitzgerald C, Merimee TJ. 1986 Insulin-like growth factors in vitreous. Diabetes. 35:416-420.
14. Crosby SR, Tsigos C, Anderton CA, Gordon C, Young RJ, White A. 1992 Elevated plasma insulin-like growth factor binding protein-1 levels in type-1 (insulin dependent) diabetic patients with peripheral neuropathy. Diabetologia. 35:868-872.
15. Britland ST, Young RJ, Sharma AK, Clarke BF. 1990 Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes. 39: 898-908.
16. Suikkari A-M, Koivisto VA, Rutanen E-M, Yki-Jarvinen H, Karonen S-L, Seppala M. 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab. 66:266-272.
17. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. 1988 Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest. 11:599-602.
18. Gordon C, Yates AP, Davies D. 1985 Evidence for a direct action of exogenous insulin on the pancreatic islets of diabetic mice: islet response to insulin preincubation. Diabetologia. 28:291-294.
19. Wang HS, Perry L A, Kanisius J, Iles RK, Holly JMP, Chard T. 1991 Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. J Endocrinol. 128:161-168.
20. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different to that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab. In press.
21. Conover CA, Butler PC, Wang M, Rizza RA, Lee PDK. 1990 Lack of growth hormone effect on insulin-associated suppression of insulin-like growth factor binding protein-1 in humans. Diabetes. 39: 1251-1256.
22. Conover CA, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. 1992 Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab. 74:1355-1360.
23. Holly JMP, Biddlecombe RA, Dunger DB, et al. 1988 Circadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf). 29:667-675.
24. Cotterill AM, Holly JMP, Amid S, Wass JAH. 1993 Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-l levels following acute hy-poglycaemia. Clin Endocrinol (Oxf). 38:633-639.
25. Ren SG, Ezzat S, Melmed S, Braunstein GD. 1992 Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology. 131: 2479-2481.
26. Ezzat S, Ren SG, Braunstein GD, Melmed S. 1992 Octreotide stimulates insulin-like growth factor binding protein-1: a potential pituitary independent mechanism for drug action. J Clin Endocrinol Metab. 75:1459-1463.
27. Hilding A, Brismar K, Thoren M, Hall K. 1993 Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 77: 1142-1147.
28. Conover CA, Divertie GD, Lee PDK. 1993 Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol (Copenh). 128:140-143.